Cathie Wood’s ARK trades RBRK, TDOC, and ZM stock on Wednesday By Investing.com

Cathie Wood’s ARK ETFs published their daily trades for Wednesday, June 12th, 2024, revealing a mix of strategic buys and sells across various sectors. Leading the transactions was a significant investment in Rubrik Inc (NASDAQ:RBRK), with ARK’s ARKW ETF purchasing 187,222 shares, totaling approximately $6.6 million in value. This move indicates a strong bullish stance on the cloud data management company.

On the sell-side, ARK’s ARKW ETF divested a total of 229,654 shares of Teladoc Health Inc (NYSE:), equating to nearly $2.4 million. Additionally, the same ETF sold 54,165 shares of Zoom Video Communications Inc (NASDAQ:) for a value of around $3.4 million. These sales might suggest a shift in ARK’s confidence in the telehealth and video communications sectors, respectively.

In the biotechnology space, ARK’s ARKG ETF continued to show interest in Arcturus Therapeutics (NASDAQ:) Holdings Inc (NASDAQ:ARCT), buying 39,589 shares valued at over $1.2 million. This follows a pattern of consistent accumulation of ARCT shares over the past week, signaling a potential long-term investment thesis in the company’s gene therapy technologies.

ARK’s ETFs also engaged in smaller-scale trades, including the purchase of 30,036 shares of Markforged Holding Corp (NYSE:MKFG) across its ARKQ and ARKX ETFs, and 18,984 shares of PagerDuty Inc (NYSE:NYSE:) through its ARKK and ARKW ETFs.

Additionally, ARK sold shares of Robinhood Markets Inc (NASDAQ:), Verve Therapeutics Inc (NASDAQ:VERV), and Zoom Video Communications Inc (NASDAQ:ZM), suggesting a recalibration of their positions in these companies.

Overall, ARK’s trading activity for the day reflects a diverse approach to portfolio management, with significant transactions in both buying and selling across different industries. Investors following ARK’s ETFs will likely keep a close eye on these moves as they try to gauge the direction of Wood’s investment strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.